Novogene Co., Ltd. (SHA:688315)
China
· Delayed Price · Currency is CNY 13.67
+0.16 (1.18%)
May 23, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Sequencing Platform Service | 952.58M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sequencing Platform Service Growth | 14.05% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Science Basic Research Services | 635.64M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Science Basic Research Services Growth | -0.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Research and Technical Services | 269.25M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Research and Technical Services Growth | 6.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business | 4.61M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business Growth | 436.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 140.03M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -28.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Coronavirus Nucleic Acid Detection | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Instruments and Consumables | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Instruments and Consumables Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Reagents | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Reagents Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Human EGFR, KRAS, BRAF, PIK3CA, ALK, ROS1 Gene Mutation Test (Semiconductor Sequencing Method) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Human EGFR, KRAS, BRAF, PIK3CA, ALK, ROS1 Gene Mutation Test (Semiconductor Sequencing Method) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| DA8600 Sequencer | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| DA8600 Sequencer Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digital PCR Chip Reader | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digital PCR Chip Reader Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| China | 1.02B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -9.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hong Kong, Macau,Taiwan and Overseas | 985.36M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hong Kong, Macau,Taiwan and Overseas Growth | 22.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|